These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24901464)

  • 1. Total daily pill burden in HIV-infected patients in the southern United States.
    Zhou S; Martin K; Corbett A; Napravnik S; Eron J; Zhu Y; Casciere B; Boulton C; Loy B; Smith S; Woods A; Murray M; Ramsdell L; Wohl DA
    AIDS Patient Care STDS; 2014 Jun; 28(6):311-7. PubMed ID: 24901464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Non-Antiretroviral Polypharmacy on the Continuity of Antiretroviral Therapy (ART) Among HIV Patients.
    Krentz HB; Gill MJ
    AIDS Patient Care STDS; 2016 Jan; 30(1):11-7. PubMed ID: 26544766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Actual medication pill burden and dosing frequency in HIV-infected patients with undetectable viral loads.
    Clay PG
    J Int Assoc Physicians AIDS Care (Chic); 2004; 3(2):49-55. PubMed ID: 15346690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving adherence and clinical outcomes through an HIV pharmacist's interventions.
    Ma A; Chen DM; Chau FM; Saberi P
    AIDS Care; 2010 Oct; 22(10):1189-94. PubMed ID: 20640958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pill burden on discontinuation of the initial HAART regimen in minority female patients prescribed 1 pill/day versus any other pill burden.
    Hill S; Kavookjian J; Qian J; Chung A; Vandewaa J
    AIDS Care; 2014; 26(5):595-601. PubMed ID: 24111921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Number of daily pills, dosing schedule, self-reported adherence and health status in 2010: a large cross-sectional study of HIV-infected patients on antiretroviral therapy.
    Gianotti N; Galli L; Bocchiola B; Cahua T; Panzini P; Zandonà D; Salpietro S; Maillard M; Danise A; Pazzi A; Lazzarin A; Castagna A
    HIV Med; 2013 Mar; 14(3):153-60. PubMed ID: 22994659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polypharmacy and risk of antiretroviral drug interactions among the aging HIV-infected population.
    Holtzman C; Armon C; Tedaldi E; Chmiel JS; Buchacz K; Wood K; Brooks JT;
    J Gen Intern Med; 2013 Oct; 28(10):1302-10. PubMed ID: 23605401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Longitudinal Analysis of Daily Pill Burden and Likelihood of Optimal Adherence to Antiretroviral Therapy Among People Living With HIV Who Use Drugs.
    Mohd Salleh NA; Richardson L; Kerr T; Shoveller J; Montaner J; Kamarulzaman A; Milloy MJ
    J Addict Med; 2018; 12(4):308-314. PubMed ID: 29521670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to antiretroviral treatment and correlation with risk of hospitalization among commercially insured HIV patients in the United States.
    Sax PE; Meyers JL; Mugavero M; Davis KL
    PLoS One; 2012; 7(2):e31591. PubMed ID: 22384040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Pill Burden on Adherence, Risk of Hospitalization, and Viral Suppression in Patients with HIV Infection and AIDS Receiving Antiretroviral Therapy.
    Scott Sutton S; Magagnoli J; Hardin JW
    Pharmacotherapy; 2016 Apr; 36(4):385-401. PubMed ID: 26923931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polypharmacy in HIV: impact of data source and gender on reported drug utilization.
    Furler MD; Einarson TR; Walmsley S; Millson M; Bendayan R
    AIDS Patient Care STDS; 2004 Oct; 18(10):568-86. PubMed ID: 15630785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Comorbidities and Polypharmacy in a Historically Minoritized Community and Their Impact on Virologic Suppression in Persons with HIV.
    Jimenez HR; Bover Manderski MT; Natali KM; Boachie N; Suh JS
    AIDS Patient Care STDS; 2023 Jun; 37(6):297-305. PubMed ID: 37294281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors for incomplete adherence to antiretroviral therapy including drug refill and clinic visits among older adults living with human immunodeficiency virus - cross-sectional study in South Africa.
    Barry A; Ford N; El-Khatib Z
    Trop Med Int Health; 2018 Mar; 23(3):270-278. PubMed ID: 29243867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved antiretroviral refill adherence in HIV-focused community pharmacies.
    Cocohoba JM; Murphy P; Pietrandoni G; Guglielmo BJ
    J Am Pharm Assoc (2003); 2012; 52(5):e67-73. PubMed ID: 23023860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of medication adherence and viral suppression in antiretroviral treatment-naïve patients with HIV/AIDS depending on the drug formulary.
    Oh KS; Han E
    PLoS One; 2021; 16(1):e0245185. PubMed ID: 33417621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-HIV Comorbid Conditions and Polypharmacy Among People Living with HIV Age 65 or Older Compared with HIV-Negative Individuals Age 65 or Older in the United States: A Retrospective Claims-Based Analysis.
    Kong AM; Pozen A; Anastos K; Kelvin EA; Nash D
    AIDS Patient Care STDS; 2019 Mar; 33(3):93-103. PubMed ID: 30844304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding HIV-Related Pill Aversion as a Distinct Barrier to Medication Adherence.
    Dorman RM; Sutton SH; Yee LM
    Behav Med; 2019; 45(4):294-303. PubMed ID: 30605010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does polypharmacy affect treatment outcomes of people living with HIV starting antiretroviral therapy?
    Khawcharoenporn T; Tanslaruk V
    Int J STD AIDS; 2020 Oct; 31(12):1195-1201. PubMed ID: 32928055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with polypharmacy and the prescription of multiple medications among persons living with HIV (PLWH) compared to non-PLWH.
    Moore HN; Mao L; Oramasionwu CU
    AIDS Care; 2015; 27(12):1443-8. PubMed ID: 26608408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of comedications and potential drug-drug interactions in people living with HIV in China.
    Chen R; Chen J; Tang Q; Meng Z; Luo L; Zhang W; Deng A; Zhang L; Wang J; Qi T; Zhang R; Shen Y; Liu L; Steinhart C; Lu H
    J Infect Chemother; 2020 Jul; 26(7):722-728. PubMed ID: 32354599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.